We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:CLDX
​
​
logo

Celldex Therapeutics (CLDX)

Nasdaq • CLDX • US15117B2025

29.87Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 14.3% of free float sold short, 6.4 days to cover, cost to borrow 0.4%. Sign up for live short interest data.

Market Cap

2.35b USD | # 3644 in US

Volume

1.34m shares | 46.85m USD

Shares Outstanding

78.53m

Free Float Shares

92.98% | 73.02m

DB:TCE2

News

CLDX key data

Celldex Therapeutics (Nasdaq: CLDX) has a market capitalization of $2.35B. Last close $29.87 (as of 2026-11-09); 52-week range $22.10 to $45.14. ORTEX data as of 2026-10-22: short interest was 14.26% of free float, 6.4 days to cover and the average cost to borrow was 0.4%. Sign up for live short interest data.

  • CLDX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.